GEP-NET
Clinical trials for GEP-NET explained in plain language.
Never miss a new study
Get alerted when new GEP-NET trials appear
Sign up with your email to follow new studies for GEP-NET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug trial offers hope for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is testing whether a new radioactive drug called RYZ101 works better than standard treatments for advanced neuroendocrine tumors of the gut and pancreas. It's for people whose tumors have grown despite previous radiation therapy. The trial will measure how long the dru…
Matched conditions: GEP-NET
Phase: PHASE3 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Researchers dig into why some neuroendocrine tumor treatments work better than others
Knowledge-focused Recruiting nowThis study aims to understand why some patients with neuroendocrine tumors respond better to treatments than others. Researchers will analyze medical records from 450 patients who received standard treatments to identify factors that influence how long treatments keep the cancer …
Matched conditions: GEP-NET
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC